1. Home
  2. CHMG vs IRWD Comparison

CHMG vs IRWD Comparison

Compare CHMG & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemung Financial Corp

CHMG

Chemung Financial Corp

HOLD

Current Price

$53.11

Market Cap

242.8M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.44

Market Cap

251.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMG
IRWD
Founded
1833
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.8M
251.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
CHMG
IRWD
Price
$53.11
$3.44
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$54.50
$5.34
AVG Volume (30 Days)
8.6K
3.7M
Earning Date
01-27-2026
11-10-2025
Dividend Yield
2.55%
N/A
EPS Growth
N/A
N/A
EPS
2.80
0.18
Revenue
$86,610,000.00
$338,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$32.65
$4.01
P/E Ratio
$19.05
$19.65
Revenue Growth
N/A
N/A
52 Week Low
$40.71
$0.53
52 Week High
$55.73
$5.13

Technical Indicators

Market Signals
Indicator
CHMG
IRWD
Relative Strength Index (RSI) 60.31 60.30
Support Level $52.11 $3.36
Resistance Level $53.76 $3.80
Average True Range (ATR) 0.69 0.33
MACD 0.25 -0.04
Stochastic Oscillator 85.89 45.88

Price Performance

Historical Comparison
CHMG
IRWD

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: